AI-assisted, human-published
04/25/2024 /Funding Events
RevOpsis Therapeutics Secures $16.5M in Seed Funding to Propel Ophthalmic Therapies
RevOpsis Therapeutics secures $16.5M in seed funding to propel ophthalmic therapies. The funding will facilitate the completion of Investigational New Drug enabling studies for
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com